pixantrone has been researched along with Borrelia hermsii Infection in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Engert, A; Gorbatchevsky, I; Herbrecht, R; Santoro, A; Zinzani, PL | 1 |
1 trial(s) available for pixantrone and Borrelia hermsii Infection
Article | Year |
---|---|
EXTEND PIX301: a phase III randomized trial of pixantrone versus other chemotherapeutic agents as third-line monotherapy in patients with relapsed, aggressive non-Hodgkin's lymphoma.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Female; Humans; Isoquinolines; Lymphoma, Non-Hodgkin; Male; Middle Aged; Relapsing Fever | 2006 |